Skip to main content Skip to section navigation Skip to footer
Global leader in temperature-controlled supply chain solutions for the life sciences
Cryport, Inc. Corporate Home
  • About Us
    • Company History
    • Management Team
  • Cryoport’s Business Units
  • ESG Policy
  • Investor Relations
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • Careers

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Executive Team
    • Contacts
    • Information Request
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Jun 21, 2016 9:23 am EDT
Cryoport Successfully Completes Its Rights Offering
Jun 20, 2016 8:30 am EDT
Cryoport Launches Next Generation Condition Monitoring Technology
Jun 16, 2016 8:30 am EDT
Cryoport to Report Fourth Quarter and Fiscal 2016 Financial Results on June 27th
Jun 15, 2016 9:15 am EDT
Cryoport Enters Bio-Storage Market
Jun 10, 2016 9:21 am EDT
Cryoport Reminds Record Date Rights Holders for the Rights Offering to Submit all Subscriptions to Their Broker or Subscription Agent
Jun 08, 2016 8:00 am EDT
Cryoport Signs Strategic Agreement to Support Tissue Solutions Transportation of Human Cells and Cryopreserved Cell Lines
May 25, 2016 9:15 am EDT
Cryoport Reminds All Interested Parties That Today is the Final Day to Become a Rights Offering Record Date Holder
May 23, 2016 8:00 am EDT
Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease
May 16, 2016 8:49 am EDT
Cryoport Announces Share Pricing Period and Record Date for Shareholder and Warrant Holder Rights Offering
May 06, 2016 9:15 am EDT
Cryoport Agreement with Cryo Store BV Expands European Presence for its Best-in-Class Cryogenic Logistics Solutions
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • …
  • Page 39
  • Next Pagearrow_forward
rss_feed News RSS
  • Accessibility statement
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
  • Cryoport Systems
  • MVE Biological Solutions
  • CRYOPDP
  • CRYOGENE
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
Cryoport, Inc. logo
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Careers
  • Newsletter
  • Manage Cookie Preferences

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

Receive Financial Updates
  • youtube
  • x
  • linkedin

Investor Contacts

Scott Eckstein
seckstein@kcsa.com

Todd Fromer
tfromer@kcsa.com

Cryoport, Inc. logo

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

©2025 Cryoport Inc. All Rights Reserved.

  • youtube
  • x
  • linkedin